-
EP2300474
European procedure
Extract from the Register of European Patents
EP About this file: EP2300474
| EP2300474 - SPIRO (PIPERIDINE-4, 2 ' -PYRROLIDINE) -1- (3, 5- TRIFLUOROMETHYL PHENYL) METHYLCARBOXAMIDES AS NK1 TACHIKYNIN RECEPTOR ANTAGONISTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.08.2013 Database last updated on 30.07.2024 | Most recent event Tooltip | 24.01.2014 | Change - lapse in a contracting state State(s) deleted from list of lapses: CY | published on 26.02.2014 [2014/09] | Applicant(s) | For all designated states Glaxo Wellcome Manufacturing Pte Ltd 1 Pioneer Sector 1 Jurong 628413 / SG | [2011/13] | Inventor(s) | 01 /
ALVARO, Giuseppe GlaxoSmithKline via Alessandro Fleming 2 I-37135 Verona / IT | 02 /
CASTIGLIONI, Emiliano GlaxoSmithKline via Alessandro Fleming 2 I-37135 Verona / IT | 03 /
MARASCO, Agostino GlaxoSmithKline via Alessandro Fleming 2 I-37135 Verona / IT | [2012/40] |
| Former [2011/13] | 01 /
ALVARO, Giuseppe GlaxoSmithKline via Alessandro Fleming 2 I-37135 Verona / IT | ||
| 02 /
CASTIGLIONI, Emiliano GlaxoSmithKline via Alessandro Fleming 2 I-37135 Verona / IT | |||
| 03 /
MARASCO, Agostino GlaxoSmithKline via Alessandro Fleming 2 I-37135 Verona / IT | Representative(s) | Pezzoli, Anna Murgitroyd & Company Piazza Borromeo, 12 20123 Milano / IT | [2013/11] |
| Former [2012/40] | Pezzoli, Anna GlaxoSmithKline 980 Great West Road Brentford Middlesex, TW8 9GS / GB | ||
| Former [2011/13] | Pezzoli, Anna GlaxoSmithKline 980 Great West Road Brentford Middlesex, TW8 9GS / GB | Application number, filing date | 09738179.2 | 29.04.2009 | [2011/13] | WO2009EP55190 | Priority number, date | GB20080008030 | 01.05.2008 Original published format: GB 0808030 | [2011/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009133135 | Date: | 05.11.2009 | Language: | EN | [2009/45] | Type: | A1 Application with search report | No.: | EP2300474 | Date: | 30.03.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.11.2009 takes the place of the publication of the European patent application. | [2011/13] | Type: | B1 Patent specification | No.: | EP2300474 | Date: | 03.10.2012 | Language: | EN | [2012/40] | Search report(s) | International search report - published on: | EP | 05.11.2009 | Classification | IPC: | C07D471/10, C07D498/20, A61P25/22, A61P25/24, A61P29/00 | [2011/13] | CPC: |
C07D471/10 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/08 (EP);
A61P1/10 (EP);
A61P1/14 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/10 (EP);
A61P15/10 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/32 (EP);
A61P25/34 (EP);
A61P25/36 (EP);
A61P29/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/13] | Extension states | AL | 26.11.2010 | BA | 26.11.2010 | RS | 26.11.2010 | Title | German: | SPIRO(PIPERIDIN-4,2ý-PYRROLIDIN)-1-(3,5-TRIFLUORMETHYLPHENYL)METHYLCARBONSÄUREAMIDE ALS ANTAGONISTEN DES NK1-TACHYKININREZEPTORS | [2011/13] | English: | SPIRO (PIPERIDINE-4, 2 ' -PYRROLIDINE) -1- (3, 5- TRIFLUOROMETHYL PHENYL) METHYLCARBOXAMIDES AS NK1 TACHIKYNIN RECEPTOR ANTAGONISTS | [2011/13] | French: | SPIRO (PIPÉRIDINE-4, 2 ' -PYRROLIDINE) -1- (3, 5- TRI FLUOROMÉTHYL PHÉNYLE) MÉTHYLCARBOXAMIDES EN TANT QU ANTAGONISTES DU RÉCEPTEUR NKL TACHIKYNINE. | [2011/13] | Entry into regional phase | 26.11.2010 | National basic fee paid | 26.11.2010 | Designation fee(s) paid | 26.11.2010 | Examination fee paid | Examination procedure | 26.11.2010 | Examination requested [2011/13] | 07.07.2011 | Despatch of a communication from the examining division (Time limit: M04) | 31.10.2011 | Reply to a communication from the examining division | 30.04.2012 | Communication of intention to grant the patent | 22.08.2012 | Fee for grant paid | 22.08.2012 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.07.2011 | Opposition(s) | 04.07.2013 | No opposition filed within time limit [2013/37] | Fees paid | Renewal fee | 06.04.2011 | Renewal fee patent year 03 | 21.03.2012 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2014/09] |
| Former [2013/52] | CY | 03.10.2012 | Cited in | International search | [A]WO9429309 (MERCK & CO INC [US], et al) [A] 1-18 * see compounds of claim 1 and neurokinin antagonistic activity *; | [A]US6013652 (MACCOSS MALCOLM [US], et al) [A] 1-18* see compounds of formula I and neurokinin antagonistic activity * | by applicant | WO9402909 | WO9429309 | US6013652 |